AR and neoplasm: When formulated with siRNA against the androgen receptor, the Glu-Urea-Lys-LNPs induced enhanced accumulation and cellular internalization at tumor sites, leading to down-regulation of androgen receptor levels and inhibition of tumor cell proliferation in a mouse xenograft model.